Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris

International Journal of Cardiology

Volumn 75, Issue 2-3, 2000, Pages 205-210

  Bednarz, Bronislaw ^a   Wolk, Robert ^a   Chamiec, Tomasz ^a   Herbaczynska Cedro, Krystyna ^b   Winek, Dariusz ^a   Ceremuzynski, Leszek ^a  

^a GROCHOWSKI HOSPITAL   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Arginine; Coronary disease; Exercise test; Ischaemia; QT dispersion

Indexed keywords

ARGININE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; EXERCISE TOLERANCE; EXHAUSTION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PULSE RATE; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; THORAX PAIN; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; ARGININE; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED;

EID: 0034664895     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00324-7     Document Type: Article

References (33)

1. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
2. The role of endogenous nitric oxide in the response of coronary blood flow to tachycardia
3. Role of nitric oxide in coronary arterial vasomotion and the influence of coronary atherosclerosis and its risks
4. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans
5. Modulation of coronary vasomotor tone in humans, Progressive endothelial dysfunction with different early stages of coronary atherosclerosis
6. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo
7. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines
8. Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris
9. Exercise-induced S.T. depression in the diagnosis of coronary artery disease: A meta-analysis
10. The effect of exercise, dobutamine and dipyridamole stress on QT dispersion in patients with coronary artery disease. Association with regional wall motion abnormality
11. Usefulness of QTc dispersion in interpreting exercise electrocardiograms
12. Increased Q.T. dispersion in patients with ventricular fibrillation following myocardial infarction
13. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease
14. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction
15. Acute ischaemia: A dynamic influence on QT dispersion
16. Effect of exercise-induced ischemia on QT interval dispersion
17. Dilator actions of arginine in human peripheral vasculature
18. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure
19. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure
20. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease
21. Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease
22. Effect of L-arginine on acetylcholine-induced endothelium-dependent vasodilation differs between the coronary and forearm vasculatures in humans
23. Dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia
24. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure
25. Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis
26. L-Arginine improves endothelium-dependent relaxation of conductance and resistance coronary arteries in coronary artery disease
27. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary arteriograms
28. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans
29. Oxidized low density lipoproteins inhibit relaxation of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide
30. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
31. Vascular effects of L-arginine: Anything beyond a substrate for the NO synthase?
32. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine
33. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischaemia? A double-blind comparison of parenteral D- and L-arginine